Exploiting CRISPR-Cas immune systems for genome editing in bacteria

Current Opinion in Biotechnology

Volumn 37, Issue , 2016, Pages 61-68

  Barrangou, Rodolphe ^a   van Pijkeren, Jan Peter ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; DNA; GENES; IMMUNE SYSTEM; MACHINERY;

CLEAVAGE SITES; DEFENSE MECHANISM; DOUBLE-STRANDED DNA BREAKS; EUKARYOTIC GENOME; INDUSTRIAL BACTERIA; MOLECULAR MACHINERY; RECOMBINEERING; SINGLE-STRANDED DNA;

NUCLEIC ACIDS;

BACTERIAL DNA;

BACTERIAL GENOME; CRISPR CAS SYSTEM; DNA REPAIR; GENETICS; HUMAN; IMMUNE SYSTEM; PROTEIN ENGINEERING;

CRISPR-CAS SYSTEMS; DNA REPAIR; DNA, BACTERIAL; GENOME, BACTERIAL; HUMANS; IMMUNE SYSTEM; PROTEIN ENGINEERING;

EID: 84947930171     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2015.10.003     Document Type: Review

References (56)

1. Pennisi E. The CRISPR craze. Science 2013, 341:833-836.
2. Ledford H. CRISPR, the dusruptor. Nature 2015, 522:20-24.
3. Mali P., Yang L., Esvelt K.M., Aach J., Guell M., Dicarlo J.E., Norville J.E., Church G.M. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
4. Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
5. Jiang W., Bikard D., Cox D., Zhang F., Marraffini L.A. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 2013, 31:233-239.
6. Oh J.H., van Pijkeren J.P. CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res 2014, 42:e131.
7. Van Pijkeren J.P., Britton R.A. Precision genome engineering in lactic acid bacteria. Microb Cell Factor 2014, 13:S10.
8. Selle K., Klaenhammer T.R., Barrangou R. CRISPR-based screening of genomic island excision events in bacteria. Proc Natl Acad Sci USA 2015, 112:8076-8081.
9. Selle K., Barrangou R. Harnessing CRISPR-Cas systems for bacterial genome editing. Trends Microbiol 2015, 23:225-232.
10. Gomaa A.A., Klumpe H.E., Luo M.L., Selle K., Barrangou R., Beisel C.L. Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. mBio 2014, 5:e00928-13.
11. Citorik R.J., Mimee M., Lu T.K. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol 2014, 32:1141-1145.
12. Bikard D., Euler C.W., Jiang W., ussenzweig P.M., Goldberg G.W., Duportet X., Fischetti V.A., Marraffini L.A. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol 2014, 32:1146-1150.
13. Sontheimer E., Barrangou R. The bacterial origins of the CRISPR genome editing revolution. Hum Gene Ther 2015, Epub PMID: 26078042.
14. Makarova K.S., Haft D.H., Barrangou R., Brouns S.J., Charpentier E., Horvath P., Moineau S., Mojica F.J., Wolf Y.I., Yakunin A.F., et al. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 2011, 9:467-477.
15. Barrangou R., Marraffini L.A. CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity. Mol Cell 2014, 54:234-244.
16. Sorek R., Lawrence C.M., Wiedenheft B. CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu Rev Biochem 2013, 82:237-266.
17. Barrangou R. CRISPR-Cas systems and RNA-guided interference. Wiley Interdiscip Rev RNA 2013, 4:267-278.
18. Van der Oost J., Westra E.R., Jackson R.N., Wiedenheft B. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol 2014, 12:479-492.
19. Barrangou R., Fremaux C., Deveau H., Richards M., Boyaval P., Moineau S., Romero D.A., Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315:1709-1712.
20. Brouns S.J., Jore M.M., Lundgren M., Westra E.R., Slijkhuis R.J., Snijders A.P., Dickman M.J., Makarova K.S., Koonin E.V., van der Oost J. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008, 321:960-964.
21. Marraffini L.A., Sontheimer E.J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 2008, 322:1843-1845.
22. Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337:816-821.
23. Garneau J.E., Dupuis M.E., Villion M., Romero D.A., Barrangou R., Boyaval P., Fremaux C., Horvath P., Magadan A.H., Moineau S. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010, 468:67-71.
24. Gasiunas G., Barrangou R., Horvath P., Siksnys V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA 2012, 109. E2579-2586.
25. Deltcheva E., Chylinski K., Sharma C.M., Gonzales K., Chao Y., Pirzada Z.A., Eckert M.R., Vogel J., Charpentier E. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 2011, 471:602-607.
26. Sapranauskas R., Gasiunas G., Fremaux C., Barrangou R., Horvath P., Siksnys V. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res 2011, 39:9275-9282.
27. Deveau H., Barrangou R., Garneau J.E., Labonte J., Fremaux C., Boyaval P., Romero D.A., Horvath P., Moineau S. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 2008, 190:1390-1400.
28. Horvath P., Romero D.A., Coute-Monvoisin A.C., Richards M., Deveau H., Moineau S., Boyaval P., Fremaux C., Barrangou R. Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J Bacteriol 2008, 190:1401-1412.
29. Mojica F.J., Diez-Villasenor C., Garcia-Martinez J., Almendros C. Short moti sequences determine the targets of the prokaryotic CRISPR defense system. Microbiology 2009, 155:733-740.
30. Sternberg S.H., Redding S., Jinek M., Greene E.C., Doudna J.A. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 2014, 507:62-67.
31. Hsu P.D., Lander E.S., Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014, 157:1262-1278.
32. Sander J.D., Joung J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 2014, 32:347-355.
33. Doudna J.A., Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014, 346. 1258096.
34. Jiang Y., Chen B., Duan C., Sun B., Yang J., Yang S. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system. Appl Environ Microbiol 2015, 81:2506-2514.
35. Pyne M.E., Moo-Young M., Chung D.A., Chou C.P. Coupling of the CRISPR/Cas9 system with Lambda Red recombineering enables simplified chromosomal gene replacement in Escherichia coli. Appl Environ Microbiol 2015, 81:5103-5114.
36. Cobb R.E., Wang Y., Zhao H. High-efficiency multiplex genome editing of Streptomyces species using en engineered CRISPR/Cas system. ACS Synth Biol 2015, 4:723-728.
37. Huang H., Zheng G., Jiang W., Hu H., Lu Y. One-step high-efficiency CRISPR/Cas-mediated genome editing in Streptomyces. Acta Biochim Biophys Sin 2015, 47:231-243.
38. Xu T., Li Y., Shi Z., Hemme C.L., Li Y., Zhu Y., van Nostrand J.D., He Z., Zhou J. Efficient genome editing in Clostridium cellulolyticum via CRISPR-Cas9 nickase. Appl Environ Microbiol 2015, 81:4423-4431.
39. Wang Y., Zhang Z.T., Seo S.O., Choi K., Lu T., Jin Y.S., Blaschek H.P. Markerless chromosomal gene deletion in Clostridium beijerinckii using CRISPR/Cas9 system. J Biotechnol 2015, 200:1-5.
40. Costantino N., Court D.L. Enhanced levels of lambda Red-mediated recombinants in mismatch repair mutants. Proc Natl Acad Sci USA 2003, 100:15748-15753.
41. Sawitzke JA, Thomason L.C., Bubunenko M., Li X., Costantino N., Court D.L. Recombineering: highly efficient in vivo genetic engineering using single-strand oligos. Methods Enzymol 2013, 533:157-177.
42. Van Pijkeren J.P., Neoh K.M., Sirias D., Findley A.S., Britton R.A. Exploring optimization parameters to increase ssDNA recombineering in Lactococcus lactis and Lactobacillus reuteri. Bioengineered 2012, 3:209-217.
43. Vercoe R.B., Chang J.T., Dy R.L., Taylor C., Gristwood T., Clulow J.S., Richter C., Przybilski R., Pitman A.R., Fineran P.C. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet 2013, 9. e1003454.
44. Qi L.S., Larson M.H., Gilbert L.A., Doudna J.A., Weissman J.S., Arkin A.P., Lim W.A. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013, 152:1173-1183.
45. Mali P., Aach J., Stranges P.B., Esvelt K.M., Moosburner M., Kosuri S., Yang L., Church G.M. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 2013, 31:833-838.
46. Maeder M.L., Linder S.J., Cascio V.M., Fu Y., Ho Q.H., Joung J.K. CRISPR RNA-guided activation of endogenous human genes. Nat Methods 2013, 10:977-979.
47. Larson M.H., Gilbert L.A., Wang X., Lim W.A., Weissman J.S., Qi L.S. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat Protoc 2013, 8:2180-2196.
48. Gilbert L.A., Larson M.H., Morsut L., Liu Z., Brar G.A., Torres S.E., Stern-Ginossar N., Brandman O., Whitehead E.H., Doudna J.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451.
49. Bikard D., Jiang W., Samai P., Hochschild A., Zhang F., Marraffini L.A. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 2013, 41:7429-7437.
50. Luo M.L., Mullis A.S., Leenay R.T., Beisel C.L. Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression. Nucleic Acids Res 2014, 43:674-681.
51. Briner A.E., Donohoue P.D., Gomaa A.A., Selle K., Slorach E.M., Nye C.H., Haurwitz R.E., Beisel C.L., May A.P., Barrangou R. Guide RNA functional modules direct Cas9 activity and orthogonality. Mol Cell 2014, 56:333-339.
52. Esvelt K.M., Mali P., Braff J.L., Moosburner M., Yaung S.J., Church G.M. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods 2013, 10:1116-1121.
53. Fonfara I., Le Rhun A., Chylinski K., Makarova K.S., Lecrivain A.L., Bzdrenga J., Koonin E.V., Charpentier E. Nucleic Acids Res 2014, 42:2577-2590.
54. Barrangou R., Horvath P. CRISPR: new horizong in phage resistance and strain identification. Annu Rev Food Sci Technol 2012, 3:143-162.
55. Barrangou R. The roles of CRISPR-Cas systems in adaptive immunity and beyond. Curr Opin Immunol 2015, 32:36-41.
56. Barrangou R., CoÛté-Monvoisin A.C., Stahl B., Chavichvily I., Damange F., Romero D.A., Boyaval P., Fremaux C., Horvath P. Genomic impact of CRISPR immunization against bacteriophages. Biochem Soc Trans 2013, 41:1383-1391.